Cargando…
Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial
BACKGROUND: Surgical site infection (SSI) is a common complication following abdominal surgery. It is associated with considerable morbidity and mortality, and its management results in significant cost to health services within both primary and secondary care. Some surgeons believe that the use of...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201898/ https://www.ncbi.nlm.nih.gov/pubmed/21970469 http://dx.doi.org/10.1186/1745-6215-12-217 |
_version_ | 1782214936752029696 |
---|---|
author | Pinkney, Thomas D Bartlett, David C Hawkins, William Mak, Tony Youssef, Haney Futaba, Kaori Harrison, Gareth Gheorghe, Adrian Bradbury, Jennifer M Calvert, Melanie J Dowswell, George Magill, Laura Redman, Val Wilson, Sue Leaper, David Morton, Dion G |
author_facet | Pinkney, Thomas D Bartlett, David C Hawkins, William Mak, Tony Youssef, Haney Futaba, Kaori Harrison, Gareth Gheorghe, Adrian Bradbury, Jennifer M Calvert, Melanie J Dowswell, George Magill, Laura Redman, Val Wilson, Sue Leaper, David Morton, Dion G |
author_sort | Pinkney, Thomas D |
collection | PubMed |
description | BACKGROUND: Surgical site infection (SSI) is a common complication following abdominal surgery. It is associated with considerable morbidity and mortality, and its management results in significant cost to health services within both primary and secondary care. Some surgeons believe that the use of a wound-edge protection device may reduce the incidence of SSI. Whilst there is some encouraging evidence showing that such devices may lead to a reduction in SSI, there are no controlled trials of sufficient size or quality to support their routine use. METHODS/DESIGN: 750 patients will be recruited from around 20 surgical units within the United Kingdom. Patients undergoing laparotomy through any major abdominal incision for any indication, elective or emergency, are eligible. Patients under the age of 18, those undergoing a laparoscopic assisted procedure or who have undergone laparotomy within the previous 3 months, and those who are unable to give informed consent will be excluded. Patients will be randomised (1:1 ratio) to the use of a wound-edge protection device or no wound-edge protection device during surgery. Follow up will consist of blinded clinical wound reviews at 5-7 days and 30-33 days postoperatively with a self-completed questionnaire covering the intervening period. Quality of life questionnaires will be completed prior to surgery and at the subsequent wound review points and information on resource usage will also be captured. The primary outcome measure is SSI within 30 days of surgery. Secondary outcomes include the impact of the degree of wound contamination, patient comorbidity, and operative characteristics on the efficacy of a wound-edge protection device in reducing SSI and whether the use of a wound-edge protection device has an effect on health-related quality of life or length of hospital stay and is cost-effective. DISCUSSION: Rossini is the first multicentre observer-blinded randomised controlled trial of sufficient size and quality to establish whether the use of a wound-edge protection device in adult patients undergoing abdominal surgery leads to a lower rate of SSI. The results of this study will be used to inform current surgical practice and may potentially benefit patients undergoing surgery in the future. TRIAL REGISTRATION NUMBER: Current Controlled Trials ISRCTN: ISRCTN40402832 |
format | Online Article Text |
id | pubmed-3201898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32018982011-10-26 Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial Pinkney, Thomas D Bartlett, David C Hawkins, William Mak, Tony Youssef, Haney Futaba, Kaori Harrison, Gareth Gheorghe, Adrian Bradbury, Jennifer M Calvert, Melanie J Dowswell, George Magill, Laura Redman, Val Wilson, Sue Leaper, David Morton, Dion G Trials Study Protocol BACKGROUND: Surgical site infection (SSI) is a common complication following abdominal surgery. It is associated with considerable morbidity and mortality, and its management results in significant cost to health services within both primary and secondary care. Some surgeons believe that the use of a wound-edge protection device may reduce the incidence of SSI. Whilst there is some encouraging evidence showing that such devices may lead to a reduction in SSI, there are no controlled trials of sufficient size or quality to support their routine use. METHODS/DESIGN: 750 patients will be recruited from around 20 surgical units within the United Kingdom. Patients undergoing laparotomy through any major abdominal incision for any indication, elective or emergency, are eligible. Patients under the age of 18, those undergoing a laparoscopic assisted procedure or who have undergone laparotomy within the previous 3 months, and those who are unable to give informed consent will be excluded. Patients will be randomised (1:1 ratio) to the use of a wound-edge protection device or no wound-edge protection device during surgery. Follow up will consist of blinded clinical wound reviews at 5-7 days and 30-33 days postoperatively with a self-completed questionnaire covering the intervening period. Quality of life questionnaires will be completed prior to surgery and at the subsequent wound review points and information on resource usage will also be captured. The primary outcome measure is SSI within 30 days of surgery. Secondary outcomes include the impact of the degree of wound contamination, patient comorbidity, and operative characteristics on the efficacy of a wound-edge protection device in reducing SSI and whether the use of a wound-edge protection device has an effect on health-related quality of life or length of hospital stay and is cost-effective. DISCUSSION: Rossini is the first multicentre observer-blinded randomised controlled trial of sufficient size and quality to establish whether the use of a wound-edge protection device in adult patients undergoing abdominal surgery leads to a lower rate of SSI. The results of this study will be used to inform current surgical practice and may potentially benefit patients undergoing surgery in the future. TRIAL REGISTRATION NUMBER: Current Controlled Trials ISRCTN: ISRCTN40402832 BioMed Central 2011-10-04 /pmc/articles/PMC3201898/ /pubmed/21970469 http://dx.doi.org/10.1186/1745-6215-12-217 Text en Copyright ©2011 Pinkney et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Pinkney, Thomas D Bartlett, David C Hawkins, William Mak, Tony Youssef, Haney Futaba, Kaori Harrison, Gareth Gheorghe, Adrian Bradbury, Jennifer M Calvert, Melanie J Dowswell, George Magill, Laura Redman, Val Wilson, Sue Leaper, David Morton, Dion G Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial |
title | Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial |
title_full | Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial |
title_fullStr | Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial |
title_full_unstemmed | Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial |
title_short | Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial |
title_sort | reduction of surgical site infection using a novel intervention (rossini): study protocol for a randomised controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201898/ https://www.ncbi.nlm.nih.gov/pubmed/21970469 http://dx.doi.org/10.1186/1745-6215-12-217 |
work_keys_str_mv | AT pinkneythomasd reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT bartlettdavidc reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT hawkinswilliam reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT maktony reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT youssefhaney reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT futabakaori reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT harrisongareth reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT gheorgheadrian reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT bradburyjenniferm reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT calvertmelaniej reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT dowswellgeorge reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT magilllaura reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT redmanval reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT wilsonsue reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT leaperdavid reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial AT mortondiong reductionofsurgicalsiteinfectionusinganovelinterventionrossinistudyprotocolforarandomisedcontrolledtrial |